Atlas Trials

Caregen Co. Ltd.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Caregen Co. Ltd.

RecordFirmDate
Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration (NCT06132035)Caregen Co. Ltd.2023-12-22
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers of the Novel Self-Administered Intranasal CG- SpikeDown Antiviral Drug (NCT05234320)Caregen Co. Ltd.2022-10-01

Track Caregen Co. Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.